Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Development of acute myeloid leukemia with NPM1 mutation, in Ph-negative clone, during treatment of CML with imatinib

Leukemia volume 26, pages 824–826 (2012)Cite this article

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 2009; 27: 6041–6605.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Groves MJ, Sales M, Baker L, Griffiths M, Pratt N, Tauro S . Factors influencing a second myeloid malignancy in patients with Philadelphia-negative-7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia. Cancer Genet 2011; 204: 39–44.

    Article  CAS  PubMed  Google Scholar 

  3. Pawarode A, Sait SN, Nganga A, Coignet LJ, Barcos M, Baer MR . Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities. Leuk Res 2007; 31: 1589–1592.

    Article  CAS  PubMed  Google Scholar 

  4. Schafhausen P, Dierlamm J, Bokemever C, Btuemmendorf TH, Bacher U, Zander AR et al. Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with imatinib. Cancer Genet Cytogenet 2009; 189: 63–67.

    Article  CAS  PubMed  Google Scholar 

  5. Dvorak P, Hruba M, Subrt I . Development of acute myeloid leukemia associated with Ph-negative clone with inv(3)(q21q26) during imatinib therapy for chronic myeloid leukemia. Leuk Res 2009; 33: 860–861.

    Article  PubMed  Google Scholar 

  6. Paquette RL, Nicoll J, Chalukya M, Gondek L, Jasek M, Sawyers CL et al. Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving dasatinib. Leuk Res 2010; 34: 708–713.

    Article  CAS  PubMed  Google Scholar 

  7. Kronke J, Schlenk RF, Jensen KO, Tschurtz F, Corbacioglu A, Gaidzik VI et al. Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group. J Clin Oncol 2011; 29: 2709–2716.

    Article  PubMed  Google Scholar 

  8. Fabarius A, Giehl M, Frank O, Duesberg P, Hochhaus A, Hehlmann R et al. Induction of centrosome and chromosome aberrations by imatinib in vitro. Leukemia 2005; 19: 1573–1578.

    Article  CAS  PubMed  Google Scholar 

  9. Bacher U, Hochhaus A, Berger U, Hiddemann W, Hehlmann R, Haferlach T et al. Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha. Leukemia 2005; 19: 460–463.

    Article  CAS  PubMed  Google Scholar 

  10. Piccaluga PP, Sabattini E, Bacci F, Agostinelli C, Righi S, Salmi F et al. Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. Leukemia 2009; 23: 1370–1371.

    Article  CAS  PubMed  Google Scholar 

  11. Soverini S, Score J, Iacobucci I, Poerio A, Lonetti A, Gnani A et al. IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis. Leukemia 2011; 25: 178–181.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hematology Lab-1st Department of Propedeutic Medicine, Laikon Hospital, Athens, Greece

    G Georgiou, A Efthymiou, I Vardounioti, M-C Kyrtsonis, P Tofas, A Bitsani, V Bartzi, I Pessach, M Dimou & P Panayiotidis

  2. Hematology Clinic, Laikon Hospital, Athens, Greece

    G Boutsikas, M K Angelopoulou, T P Vassilakopoulos & E Plata

Authors
  1. G Georgiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Efthymiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I Vardounioti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G Boutsikas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M K Angelopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T P Vassilakopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M-C Kyrtsonis
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E Plata
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P Tofas
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A Bitsani
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. V Bartzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. I Pessach
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. M Dimou
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. P Panayiotidis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G Georgiou.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Georgiou, G., Efthymiou, A., Vardounioti, I. et al. Development of acute myeloid leukemia with NPM1 mutation, in Ph-negative clone, during treatment of CML with imatinib. Leukemia 26, 824–826 (2012). https://doi.org/10.1038/leu.2011.280

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2011.280

This article is cited by

Search

Advanced search

Quick links